一个集群随机试验的简短的多组件干预措施,以改善烟草在物质使用治疗的结果
Joseph Guydish1, Caravella McCuistian2, Sindhushree Hosakote2
1Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 490 Illinois St., Floor 7, San Francisco, CA, 94158, USA. joseph.guydish@ucsf.edu.
Substance abuse treatment, prevention, and policy
|June 16, 2023
概括
在药物使用障碍 (SUD) 治疗中戒烟的简短干预并没有减少员工或客户的吸烟率. 需要进一步的研究来为这一群体制定有效的戒烟策略.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 在接受物质使用障碍 (SUD) 治疗的个人中,吸烟的发病率很高.
- 现有的戒烟干预措施往往是复杂和漫长的,这给SUD计划带来了挑战.
研究的目的:
- 评估一个简短的,多组件干预措施对SUD治疗中工作人员和客户的烟草结果的影响.
- 为了确定简化干预是否可以有效地解决SUD治疗环境中的戒烟问题.
主要方法:
- 一个集群随机试验,涉及七个SUD治疗方案,分配给多组分干预或等候名单对照组.
- 6个月的干预包括领导力激励,计划激励,员工培训和领导力学习社区.
- 来自员工和客户的调查数据在干预前和干预后收集,用于结果分析.
主要成果:
- 在干预组和对照组之间的员工中,在吸烟流行率,自我有效性或戒烟实践方面没有发现显著差异.
- 与对照组相比,干预组的客户在吸烟流行或接受烟草服务方面没有显著差异.
- 虽然整体吸烟率在干预前后降低,但这种变化不能归因于干预.
结论:
- 经过测试的简短多组分干预措施在改变SUD治疗中的客户吸烟患病率或烟草相关服务方面没有效果.
- 需要新的,可能更为密集的干预策略,才能有效地减少吸烟者在物质使用障碍.
相关概念视频
Randomized Experiments
7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.1K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Community Based Intervention
66
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
66
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Study Designs in Epidemiology
288
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
288
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166


